May 17, 2026Biocell Ltd announces it has been granted JP patent for OPX – its novel development for prostate cancer preventionUnited Kingdom, London, February 20, 2026 – Biocell Ltd announces it has been granted JP patent for OPX – its […]
May 17, 2026Biocell Ltd granted Canadian patent for OBX- Novel breast cancer risk reduction and therapy drug candidateLONDON, UNITED KINGDOM, August 26, 2025 – Biocell Ltd announces it has been granted an JP patent for its novel […]
May 17, 2026Biocell Ltd granted JP patent for OBX- Novel breast cancer risk reduction and therapy drug candidateLONDON, UNITED KINGDOM, December 18, 2025 – Biocell Ltd announces it has been granted an JP patent for its novel […]
February 24, 2025Biocell Ltd Granted EU Patent for OBX – Novel breast cancer risk reduction and therapy drug candidateLONDON, UNITED KINGDOM, February 24, 2025 /EINPresswire.com/ — Biocell Ltd announces it has been granted an EU patent for its […]
February 5, 2024Biocell announces it received positive PCT International search opinions for its patent applications for OBX and OPX
July 21, 2023Biocell announces the interim results of the retrospective real world study data for OUX users